Category: Biotechnology
Europe Biotechnology
-
2023-2027 Albania Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Moldova Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Italy Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Ukraine Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Europe Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - A 38-Country Database and Analysis, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new 38-country report from LeadingMarketResearch.com This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Poland Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Switzerland Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
Poultry Diagnostics Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Test Type [Enzyme-Linked Immunosorbent Assay (ELISA) Tests, Polymerase Chain Reaction (PCR) Test, Hemagglutination-Inhibition (HI), and Others], Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... and Others], Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) According to our new ... Read More
-
Europe Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type (Cell Culture Media Bioprocess, Chromatography Bioprocess, and Consumables & Accessories, and Others), Modality (Single Use and Multiple Use), and End User (Academic & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others)
... Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others) The Europe bioprocess technology market is expected to grow from US$ 12,290.88 million in 2023 to US$ 26,588.36 million by 2028. It is estimated to grow at ... Read More
-
Cell and Gene Therapy Manufacturing Services Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopaedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... and Non-Viral Vector)], Indication (Cancer, Orthopaedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Geography (North America, Europe, Asia Pacific, Middle East & ... Read More
-
Biopreservation Media Providers Market by Preservation Condition (Refrigerated, Frozen / Cold Chain, Frozen (Ultra-low) / Deep Frozen, and Cryogenic / LN2 Vapor Phase Storage), Type of Serum (Fetal Bovine Serum Containing Media, Fetal Calf Serum Containing Media, Human Serum Containing Media, and Serum Free Media), Type of Biological Sample (Germline Cells / Stem Cells, Organs, Somatic Cells, and Tissues), Type of Packaging Format (Bags, Bottles, Vials, and Others), Area of Application (Diagnostic Use, Research and Development, and Therapeutic Use), End Users (Academic and Research Institutes, Biobanks / Genebanks, Hospitals, Pharmaceutical and Biotechnology Companies, and Other End Users), and Region (North America, Europe, Asia, MENA, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2021-2035
... Containing Media, Human Serum Containing Media, and Serum Free Media), Type of Biological Sample (Germline Cells / Stem Cells, Organs, Somatic Cells, and Tissues), Type of Packaging Format (Bags, Bottles, Vials, and Others), Area of ... Read More
-
Europe Organ Preservation Solutions Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type [University of Wisconsin Solution (UW), Custodiol HTK, Perfadex, Hypothermosol, and Others], Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Organ Type (Kidneys, Liver, Lungs, Heart, and Others), and End User (Organ Transplant Centers, Hospitals, and Specialty Clinics)
... Normothermic Machine Perfusion, and Others), Organ Type (Kidneys, Liver, Lungs, Heart, and Others), and End User (Organ Transplant Centers, Hospitals, and Specialty Clinics) The Europe organ preservation solutions market is expected to grow from US$ ... Read More
-
UK Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030
... Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 UK Early Toxicity Testing Market was valued at USD 158.42 million in 2022, and is predicted to reach USD 289.77 million by 2030, ... Read More
-
Spain Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030
... Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 Spain Early Toxicity Testing Market was valued at USD 35.3 million in 2022, and is predicted to reach USD 99.66 million by 2030, ... Read More
-
Finland Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030
... Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 Finland Early Toxicity Testing Market was valued at USD 5.27 million in 2022, and is predicted to reach USD 33.29 million by 2030, ... Read More
-
Norway Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030
... Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 Norway Early Toxicity Testing Market was valued at USD 32.19 million in 2022, and is predicted to reach USD 83.45 million by 2030, ... Read More
-
Germany Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030
... Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 Germany Early Toxicity Testing Market was valued at USD 246.68 million in 2022, and is predicted to reach USD 422.28 million by 2030, ... Read More
-
Europe Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030
... Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 Europe Early Toxicity Testing Market was valued at USD 1.07 billion in 2022, and is predicted to reach USD 2.19 billion by 2030, ... Read More
-
Denmark Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030
... Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 Denmark Early Toxicity Testing Market was valued at USD 18.68 million in 2022, and is predicted to reach USD 67.9 million by 2030, ... Read More
-
Italy Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030
... Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 Italy Early Toxicity Testing Market was valued at USD 46.67 million in 2022, and is predicted to reach USD 100.09 million by 2030, ... Read More
-
Sweden Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030
... Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 Sweden Early Toxicity Testing Market was valued at USD 3.66 million in 2022, and is predicted to reach USD 19.93 million by 2030, ... Read More
-
Netherlands Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030
... Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 Netherlands Early Toxicity Testing Market was valued at USD 44.95 million in 2022, and is predicted to reach USD 106.45 million by 2030, ... Read More
-
France Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030
... Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 France Early Toxicity Testing Market was valued at USD 129.68 million in 2022, and is predicted to reach USD 259.76 million by 2030, ... Read More
-
Europe Organoids Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells)
... Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells) The Europe organoids market is expected to grow from US$ 1,018.12 million in 2023 ... Read More
-
Europe Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Service Type (Lyophilization Cycle Development, Clinical Manufacturing, Commercial Manufacturing, and Freeze Drying Analytical Services) and End User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Others)
... & Biotechnology Companies, Research Institutes, and Others) The Europe lyophilization services for biopharmaceuticals market is expected to grow from US$ 799.18 million in 2023 to US$ 1,244.89 million by 2028. It is estimated to register ... Read More
Research Assistance
